Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA-DR associated immune responsiveness.

D J Cook

    Clinical Transplants
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    HLA-DR1 positivity significantly improves kidney transplant graft survival across various donor types and immunosuppression strategies. This finding highlights the importance of human leukocyte antigen (HLA) matching in transplantation outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Fall Detection in Smart Home Environments Using UWB Sensors and Unsupervised Change Detection.

    Journal of reliable intelligent environments·2025
    Same author

    Brain Charts for the Rhesus Macaque Lifespan.

    bioRxiv : the preprint server for biology·2024
    Same author

    Abstracts of presentations to the Annual Meetings of the Canadian Society of Colon and Rectal Surgeons Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons: Canadian Surgery Forum, London, Ont., Sept. 19 to 22, 2002.

    Canadian journal of surgery. Journal canadien de chirurgie·2023
    Same author

    The Association between Frailty and Short-Term Outcomes in an Intensive Care Unit Rehabilitation Trial: An Exploratory Analysis.

    The Journal of frailty & aging·2020
    Same author

    Protocol adherence for continuously titrated interventions in randomized trials: an overview of the current methodology and case study.

    BMC medical research methodology·2017
    Same author

    The monitoring of activity at home after total hip arthroplasty.

    The bone & joint journal·2016
    Same journal

    Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study.

    Clinical transplants·2017
    Same journal

    Influenza Immunization and the Generation of Anti-HLA and Anti-MICA Antibodies in Patients with Renal Failure and in Kidney Transplant Recipients.

    Clinical transplants·2017
    Same journal

    From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays.

    Clinical transplants·2017
    Same journal

    Post-transplant Desensitization for Deceased Donor Kidney Transplant Recipients: A Single Center Experience.

    Clinical transplants·2017
    Same journal

    Acute Rejection in 6-Antigen HLA-Matched Kidney Transplant Recipients: Risk Factors and Outcomes from the Wisconsin Allograft Recipient Database (WisARD).

    Clinical transplants·2017
    Same journal

    C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Kidney Transplant Recipients.

    Clinical transplants·2017
    See all related articles

    Area of Science:

    • Immunogenetics
    • Transplantation immunology
    • Nephrology

    Background:

    • Human Leukocyte Antigen (HLA) compatibility is crucial for successful organ transplantation.
    • The role of specific HLA-DR antigens, particularly HLA-DR1, in kidney transplant outcomes requires further elucidation.
    • Immunosuppressive therapies, such as Cyclosporine A (CsA), are standard in preventing graft rejection.

    Purpose of the Study:

    • To investigate the impact of HLA-DR1 positivity on kidney graft survival rates.
    • To analyze the association of HLA-DR1 and other HLA-DR antigens (DR4, DRw9, DRw6) with transplant outcomes.
    • To evaluate the influence of HLA-DR antigen status on graft survival in conjunction with immunosuppression.

    Main Methods:

    • Retrospective analysis of kidney transplant recipients from 1980 and 1983 onwards.

    Related Experiment Videos

  • Comparison of graft survival rates between HLA-DR1-positive and HLA-DR1-negative patient groups.
  • Stratification of data based on donor type (cadaver, living-related), recipient race, and immunosuppression (CsA use).

    • Main Results:

    • HLA-DR1-positive recipients demonstrated significantly superior kidney graft survival (72.5% vs. 66.5%, p<0.00001) compared to DR1-negative patients.
    • This advantage was observed across first cadaver, regraft, and living-related donor transplants, irrespective of DR-antigen matching.
    • DR1 positivity conferred better graft survival in both white and black recipients; DR4 positivity also showed good outcomes in black recipients. DRw9 showed variable outcomes with CsA, and DRw6 was associated with poorer survival in later transplants.

    Conclusions:

    • HLA-DR1 positivity is a significant predictor of enhanced kidney graft survival.
    • The beneficial effect of HLA-DR1 is evident early post-transplant and is independent of the degree of DR-antigen matching or CsA use.
    • Further research is warranted to understand the unique immunogenetic profiles of DR1 and DR4 positive recipients.